SCHEMBL30120484

SCHEMBL30120484

CC(C)(C)OC(=O)CN1CCN(c2ccc(NC3CCC(=O)NC3=O)cc2F)CC1

nearest known ligand 0.53

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 18/20 0.53
DDB1 Q16531 16/20 0.53
HDAC8 Q9BY41 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23799119 1.00 CRBN (0.53) CRBNDDB1HDAC8
SCHEMBL31334549 0.94 CRBN (0.48) CRBNDDB1HDAC8
SCHEMBL30915148 0.91 CRBN (0.51) CRBNDDB1HDAC8
SCHEMBL31390678 0.88 CRBN (0.49) CRBNDDB1HDAC8
SCHEMBL31334208 0.88 CRBN (0.49) CRBNDDB1HDAC8
SCHEMBL23540366 0.88 CRBN (0.49) CRBNDDB1HDAC8
SCHEMBL23551320 0.88 CRBN (0.49) CRBNDDB1HDAC8
SCHEMBL23551319 0.88 CRBN (0.49) CRBNDDB1HDAC8
SCHEMBL30120249 0.88 CRBN (0.49) CRBNDDB1HDAC8
SCHEMBL30120231 0.88 CRBN (0.49) CRBNDDB1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4351583-A1 THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF C4 Therapeutics, Inc. (US) 2024-04-17 EP disclosed
WO-2022261250-A1 THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF C4 THERAPEUTICS, INC. (US) 2022-12-15 WO disclosed